Suchergebnisse - "Bhalla, Kapil"

PubPharm (21)

1

Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells

enthalten in: Oncotarget | 2014

von Ha, K. | Fiskus, W. | Choi, D. | +9

2

Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells

enthalten in: Molecular cancer therapeutics | 2013

von Fiskus, W. | Verstovsek, S. | Manshouri, T. | +5

3

Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer

enthalten in: Oncotarget | 2012

von Venkannagari, S. | Fiskus, W. | Peth, K. | +4

4

Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells

enthalten in: Breast cancer research and treatment | 2012

von Fiskus, W. | Hembruff, S. | Rao, R. | +7

5

Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cells

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2011

von Fiskus, W. | Verstovsek, S. | Manshouri, T. | +10

6

Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage

enthalten in: Molecular cancer therapeutics | 2011

von Ha, K. | Fiskus, W. | Rao, R. | +4

7

Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery

enthalten in: Human molecular genetics | 2011

von Ha, K. | Lee, G. | Palii, S. | +5

8

Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells

enthalten in: Molecular cancer therapeutics | 2010

von Rao, R. | Nalluri, S. | Kolhe, R. | +10

9

Activation of mTOR : A new mechanism "PIMed"

enthalten in: Cancer biology & therapy | 2009

von Buckley, K. | Fiskus, W. | Bhalla, K.

CommentOn: Cancer Biol Ther. 2009 May;8(9):846-53. - PMID 19276681

10

HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells

enthalten in: Blood | 2008

von Rao, R. | Fiskus, W. | Yang, Y. | +7